US Patent 7566784 Bicyclic heterocycles as kinase inhibitors
Patent 7566784 was granted and assigned to Bristol-Myers Squibb on July, 2009 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7566784 Bicyclic heterocycles as kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
